文献速递系统性红斑狼疮

增殖性狼疮肾炎肾脏结局的早期预测因素:36个月队列研究

Early predictors of renal outcome in patients with proliferative lupus nephritis: a 36-month cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该回顾性队列研究纳入104例活检证实的增殖性狼疮肾炎(LN)患者,随访36个月,评估完全肾脏缓解(CRR)和肾脏复发的早期预测因素。结果显示91.7%患者达到CRR,中位时间6.0个月;基线及诱导治疗3个月时蛋白尿<2 g/day是CRR的独立预测因素;诊断时年龄≤25岁和抗RNP阳性是肾脏复发的独立预测因素。

要点

  • 基线及诱导治疗3个月时蛋白尿<2 g/day可独立预测增殖性LN患者达到CRR。
  • LN诊断时年龄≤25岁和抗RNP阳性是达到CRR后肾脏复发的独立预测因素。
  • 91.7%患者达到CRR,中位时间6.0个月;18.4%达到CRR者发生肾脏复发。

核心结论

  • 在SLE合并增殖性LN患者中,基线和诱导治疗3个月时评估的因素可预测CRR及达到CRR后的肾脏复发。

研究设计与样本

  • 回顾性队列研究,随访36个月,纳入两家欧洲三级中心104例活检证实的增殖性LN(III/IV型)患者,采用生存分析。

主要发现

  • 91.7%患者达到CRR,中位时间6.0个月;18.4%达到CRR者发生肾脏复发,平均时间16.5(8.6)个月。
  • 基线蛋白尿<2 g/day(HR=1.80,95%CI 1.16,2.79,P<0.01)和诱导治疗3个月时蛋白尿<2 g/day(HR=2.32,95%CI 1.24,4.32,P<0.01)是CRR的独立预测因素。
  • LN诊断时年龄≤25岁(HR=5.41,95%CI 1.72,16.97,P<0.01)和抗RNP阳性(HR=3.52,95%CI 1.21,10.20,P=0.02)是肾脏复发的独立预测因素。

关键数值与推荐

  • CRR定义为蛋白尿<0.5 g/day且肾功能正常;肾脏复发定义为达到CRR后蛋白尿>1 g/day。
  • 单因素分析中P<0.10的变量进入多因素Cox比例风险回归模型。

临床怎么用

  • 对增殖性LN患者,应关注基线及诱导治疗3个月时的蛋白尿水平以预测CRR。
  • 对诊断时年龄≤25岁或抗RNP阳性的患者,达到CRR后需警惕肾脏复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify predictors of complete renal response (CRR) and renal flares in SLE patients with active proliferative LN. METHODS: This was a retrospective cohort study over 36 months including patients with biopsy-proven proliferative LN (class III/IV), from two European tertiary centres. CRR and renal flare were defined as proteinuria <0.5 g/day with normal renal function and proteinuria >1 g/day after CRR attainment, respectively. Demographic, clinical and analytic parameters were evaluated as early predictors of renal outcome, using survival analysis. Candidate variables were tested as predictors for CRR at time 0, 3 and 6 months after starting induction treatment. Potential predictors for renal flare were evaluated at time of reaching CRR. Variables with P < 0.10 on univariate analysis with log-rank tests were further tested with multivariate Cox proportional hazards regression models. RESULTS: We included 104 patients [81.7% female, mean (s.d.) age at baseline 32.0 (13.3) years]. Over follow-up, 91.7% reached CRR, within a median time of 6.0 months. Proteinuria <2 g/day at baseline [hazard ratio (HR) = 1.80, 95% CI 1.16, 2.79, P < 0.01] and 3 months (HR = 2.32, 95% CI 1.24, 4.32, P < 0.01) after starting induction therapy were independent predictors of CRR. Renal flares occurred in 18.4% of patients reaching CRR, after a mean time of 16.5 (8.6) months. Age up to 25 years at time of LN diagnosis (HR = 5.41, 95% CI 1.72, 16.97, P < 0.01) and positive anti-RNP (HR = 3.52, 95% CI 1.21, 10.20, P = 0.02) were independent predictors of renal flares. CONCLUSION: In patients with SLE and proliferative LN, factors assessed at baseline and 3 months from starting induction treatment can predict CRR and renal flares once CRR is achieved.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Luís MSF, Bultink IEM, da Silva JAP, et al. Early predictors of renal outcome in patients with proliferative lupus nephritis: a 36-month cohort study. Rheumatology (Oxford). 2021. PMID: 33560332. doi:10.1093/rheumatology/keab126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。